MyFinsight
Home
Blog
About
Back
Income Statement
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)
source: myfinsight.com
Comprehensive loss
-$159,393K
Net loss
-$158,986K
Unrealized gain/(loss) on
investments
-$406K
Loss on foreign
currency translation
-$1K
Total other
income/(expense)
-$83,909K
Loss from operations
-$75,077K
Interest income
$3,587K
Change in fair value of
2022 usd financing...
$86,231K
Total operating
expenses
$75,077K
Interest expense
$1,233K
Foreign exchange loss,
net
-$32K
Research and development
$48,665K
General and
administrative
$26,412K
Back